Differential regulation of low and high voltage-activated calcium channels in neonatal rat myocytes following chronic PKA modulation

Channels (Austin). 2011 Jul-Aug;5(4):357-66. doi: 10.4161/chan.5.4.17121. Epub 2011 Jul 1.

Abstract

The biophysical properties of voltage-dependent cardiac calcium channels (VDCC) can be modulated by protein kinases. In this study, we investigate whether long-term treatment with protein kinase A (PKA) modulators alters the VDCC activity in neonatal ventricular myocytes. Using whole-cell patch-clamp recordings, we found an increase in high-voltage activated (HVA) current density and a corresponding decrease in low-voltage activated (LVA) current density in neonatal rat ventricular myocytes up to 6 days in culture. Long-term exposure to 8Br-cAMP, a PKA stimulator, increased the HVA current density at 7 and 24 hours. In contrast, H89, a PKA inhibitor, caused a biphasic change in the HVA, an initial reduction at 7 hours exposure followed by an increase up to 4 days. In addition, H89 caused a sustained increase in LVA currents from 7 hours to 4 days. These findings suggest that chronic exposure to H89 changes LVA and HVA calcium current activities in cardiac myocytes. PKA is a key target of β-adrenoceptor activiation, thus, our findings suggest long-term repeated use of β-adrenergic drugs may induce unexpected functional alteration of VDCCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Calcium Channels / metabolism*
  • Cells, Cultured
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Enzyme Activators / pharmacology
  • Heart Ventricles / cytology
  • Heart Ventricles / metabolism*
  • Isoquinolines / pharmacology
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology*
  • Muscle Proteins / agonists
  • Muscle Proteins / antagonists & inhibitors
  • Muscle Proteins / metabolism*
  • Myocytes, Cardiac / cytology
  • Myocytes, Cardiac / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Rats
  • Receptors, Adrenergic, beta / metabolism
  • Sulfonamides / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Calcium Channels
  • Enzyme Activators
  • Isoquinolines
  • Muscle Proteins
  • Protein Kinase Inhibitors
  • Receptors, Adrenergic, beta
  • Sulfonamides
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide